PRP Therapy in Orthopaedic Practice: From Symptom Control to Biological Healing
For decades, orthopaedic treatment strategies were largely centered on symptom control—reducing pain, limiting inflammation, and restoring mobility through mechanical support or surgical intervention. While effective, these methods often failed to address the underlying biological deficits responsible for chronic degeneration and delayed healing.
PRP therapy represents a paradigm shift. Rather than masking symptoms, it aims to biologically influence tissue repair. Platelets contain a complex mixture of growth factors, cytokines, and bioactive proteins that regulate inflammation and stimulate cellular regeneration at the injury site.
In orthopaedic applications, PRP has demonstrated particular value in degenerative and overuse conditions such as knee osteoarthritis, lateral epicondylitis, Achilles tendinopathy, and rotator cuff pathology. The clinical benefit is closely tied to appropriate patient selection, disease stage, and protocol standardization.
Recent evidence supports PRP’s role in reducing pain scores, improving functional outcomes, and delaying surgical intervention in selected patient populations. Importantly, PRP is not positioned as a replacement for surgery, but as an adjunct or early intervention that can optimize tissue quality and recovery timelines.
From an academic perspective, reproducibility remains the critical factor. PRP prepared with certified, closed-system devices ensures consistent platelet concentration and minimizes contamination risk. This consistency is essential for aligning real-world outcomes with published clinical data.
As orthopaedic medicine continues to integrate biologics, PRP stands out as one of the most studied and clinically applicable regenerative therapies available today. Its success reflects a broader movement toward precision, personalization, and biological intelligence in musculoskeletal care.
